Received Oct 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | Z005765 | IM / RA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 4YA34 | IM / LA |
Immediate onset of URI symptoms post injection including chest congestion, ST and malaise. Treated for bronchospasm when symptoms persisted >2 weeks.
none
GERD, depression/anxiety, OSA, IBS, Hyperli
Amlodipine, Lexapro, Levothyroxine, Multivitamin, Pravastatin, Spironolactone
Citalopram, Effexor, Fluoxetine
none